ArticlePharmacological research2020

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection.

Roberto Maggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.